Response to Cabozantinib Following Acquired Entrectinib Resistance in a Patient With ETV6-NTRK3 Fusion-Positive Carcinoma Harboring the NTRK3G623R Solvent-Front Mutation. (2021) - Hanf, Dorothea; Heining, Christoph; Laaber, Karin; Nebelung, Heiner; Uhrig, Sebastian; Hutter, Barbara; Jahn, Arne; Richter, Daniela; Aust, Daniela; Herbst, Friederike; Fröhling, Stefan; Glimm, Hanno; et al.